THIS ARTICLE/PRESS RELEASE IS PAID FOR AND PRESENTED BY NTNU Norwegian University of Science and Technology - read more
New app helps relieve back pain
Back pain is very common. But a new app called selfBACK can help us get better.
Back problems are among the most common causes of sick leave. Every year as many as one in 15 adults in Norway sees a doctor or physiotherapist due to lower back pain. Worldwide, back pain is the most common cause of disability.
Many people are afraid to be physically active when they experience back pain, but reducing the activity level often prolongs or even aggravates the condition.
“We can do a lot ourselves to reduce back pain through exercise and lifestyle adjustments,” says Paul Jarle Mork, a professor at NTNU’s Department of Public Health and Nursing. “A better understanding of the possible causes of back ailments also provides a better starting point for dealing with the pain on your own. However, self-management can be difficult to implement without any kind of help or support along the way.”
Professor Mork has collaborated with Kerstin Bach, an associate professor at NTNU’s Department of Computer Science, to lead the work of developing the system for a new app called selfBACK.
The solution will enable more people to deal with back pain in a better way, and could potentially bring huge savings for people’s working life and for society.
Advice tailored to your back problems
“Hundreds of health apps are already available for mobile phones. But the selfBACK app stands out by being based on sound scientific evidence,” says Mork.
The app explains what back pain is, and it tailors advice and feedback to actions you can take to deal with the pain, including physical activity and exercise.
Each week, the app provides you with your own customized plan to follow. Since the app uses artificial intelligence and draws on other people’s experiences with back pain, the advice you receive will be specially personalized for your needs.
“So before you start to use the app, you have to answer some questions, including about your lifestyle and specific back problems. The app compares your answers to those of other app users, and to the results they’ve achieved by using the app. This is how the app can adapt the advice for you,” says Bach.
Many study participants felt much better
To evaluate the effect of the selfBACK app, the researchers conducted a randomized controlled trial that included 461 patients with back pain from Norway and Denmark.
“About half of the study participants received standard treatment from their health providers. The other half received standard treatment as well, but also used selfBACK,” says Mork explains.
Participants reported on their progress after three, six and nine months of using the app.
After three months, 39 per cent of the participants in the control group reported that they had experienced major improvements in their back pain, compared to 52 per cent of the participants who used the selfBACK app.
This means that the probability of a major improvement was about 32 per cent higher for participants who used selfBACK. The same differences were also present after six and nine months.
Five years and five million from the EU
The work of developing and evaluating the selfBACK system has taken five years, but the results are very promising. Using the selfBACK app as a supplement to regular treatment shows positive results for individuals who want to relieve their back pain.
The EU has supported the selfBACK project with five million euros – a strong indicator of good faith in the new app. The results of the randomized controlled trial were recently published in JAMA Internal Medicine.
The University of Southern Denmark (DK), Robert Gordon University (UK), the University of Glasgow (UK), the National Research Center for the Working Environment (DK), Health Leads (NL) and Trade Expansion (DK) are partners in the project.
Lousie Fleng Sandal et.al.: Effectiveness of App-Delivered, Tailored Self-Management Support for Adults With Lower Back Pain-Related Disability. JAMA Internal Medicine, August 2021.